Search research articles
Contact Us
Filters
Showing results (151-160 of 161) with videos related to
Page
of 17
Sort By:
Scientific Reports
|
September 10, 2016
Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Scientific Reports
|
October 11, 2016
Corrigendum: Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Antibiotics (Basel, Switzerland)
|
December 11, 2019
Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification
Katharigatta N Venugopala, Christophe Tratrat, Melendhran Pillay, et al.
Plos One
|
June 5, 2019
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues
Katharigatta Narayanaswamy Venugopala, Sandeep Chandrashekharappa, Melendhran Pillay, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector <i>Anopheles arabiensis</i> and In Silico Molecular Docking Study
Katharigatta N Venugopala, Pottathil Shinu, Christophe Tratrat, et al.
Antibiotics (Basel, Switzerland)
|
June 25, 2020
Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues
Katharigatta N Venugopala, Mohammed A Khedr, Yarabahally R Girish, et al.
International Journal of Biological Macromolecules
|
June 26, 2024
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies
Katharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 2, 2021
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
Katharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Molecules (Basel, Switzerland)
|
March 19, 2020
Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector <i>Anopheles arabiensis</i>, In Silico ADMET Prediction and Molecular Target Investigation
Katharigatta N Venugopala, Pushpalatha Ramachandra, Christophe Tratrat, et al.
Journal of Alzheimer'S Disease : JAD
|
January 17, 2022
A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics
Mohammad Nami, Robert Thatcher, Nasser Kashou, et al.
Page
of 17
Search research articles
Search
Showing results (151-160 of 161) with videos related to
Sort By:
Page
of 17
Scientific Reports
|
September 10, 2016
Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Scientific Reports
|
October 11, 2016
Corrigendum: Identification of Altered Metabolomic Profiles Following a Panchakarma-based Ayurvedic Intervention in Healthy Subjects: The Self-Directed Biological Transformation Initiative (SBTI)
Christine Tara Peterson, Joseph Lucas, Lisa St John-Williams, et al.
Antibiotics (Basel, Switzerland)
|
December 11, 2019
Anti-Tubercular Activity of Substituted 7-Methyl and 7-Formylindolizines and In Silico Study for Prospective Molecular Target Identification
Katharigatta N Venugopala, Christophe Tratrat, Melendhran Pillay, et al.
Plos One
|
June 5, 2019
Computational, crystallographic studies, cytotoxicity and anti-tubercular activity of substituted 7-methoxy-indolizine analogues
Katharigatta Narayanaswamy Venugopala, Sandeep Chandrashekharappa, Melendhran Pillay, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
1,2,3-Triazolyl-tetrahydropyrimidine Conjugates as Potential Sterol Carrier Protein-2 Inhibitors: Larvicidal Activity against the Malaria Vector <i>Anopheles arabiensis</i> and In Silico Molecular Docking Study
Katharigatta N Venugopala, Pottathil Shinu, Christophe Tratrat, et al.
Antibiotics (Basel, Switzerland)
|
June 25, 2020
Crystallography, in Silico Studies, and In Vitro Antifungal Studies of 2,4,5 Trisubstituted 1,2,3-Triazole Analogues
Katharigatta N Venugopala, Mohammed A Khedr, Yarabahally R Girish, et al.
International Journal of Biological Macromolecules
|
June 26, 2024
Identification of potent indolizine derivatives against Mycobacterial tuberculosis: In vitro anti-TB properties, in silico target validation, molecular docking and dynamics studies
Katharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
July 2, 2021
Anti-tubercular activity and molecular docking studies of indolizine derivatives targeting mycobacterial InhA enzyme
Katharigatta N Venugopala, Sandeep Chandrashekharappa, Pran Kishore Deb, et al.
Molecules (Basel, Switzerland)
|
March 19, 2020
Larvicidal Activities of 2-Aryl-2,3-Dihydroquinazolin -4-ones against Malaria Vector <i>Anopheles arabiensis</i>, In Silico ADMET Prediction and Molecular Target Investigation
Katharigatta N Venugopala, Pushpalatha Ramachandra, Christophe Tratrat, et al.
Journal of Alzheimer'S Disease : JAD
|
January 17, 2022
A Proposed Brain-, Spine-, and Mental- Health Screening Methodology (NEUROSCREEN) for Healthcare Systems: Position of the Society for Brain Mapping and Therapeutics
Mohammad Nami, Robert Thatcher, Nasser Kashou, et al.
Page
of 17